Abstracts
Bethesda Conference 24

Cardiac Transplantation
November 5-5, 1992
Published: Vol 22, No 1, Jul 93:1-64 Journal of the American College of Cardiology

Over the past decade, heart transplantation has evolved from a rarely performed experimental procedure to an accepted therapy for end-stage heart disease. The understanding of the immune response at increasingly fundamental levels combined with information from in vivo models of organ transplantation have enabled rapid advances in the development of new immunosuppressive modalities. This Conference report addresses both future developments in immunosuppression which may help optimize the use of scarce cardiac allografts, and the potential alternatives to allotransplantation which may minimize, if not obviate, the need for human donor hearts.

Copyright © 2000 American College of Cardiology

ADVERTISEMENT








Back to Top | | Copyright © 2008 American College of Cardiology
ACCInTouch Facebook Twitter LinkedIn
Heart House | 2400 N Street, NW | Washington, DC 20037